A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results

被引：0
|
作者：
Voortman, J.
Smit, E. F.
Kuenen, B. C.
van de Velde, H.
Giaccone, G.
机构：
[1] VU Univ Med Ctr, Amsterdam, Netherlands
[2] Johnson & Johnson, Pharmaceut Res & Dev, Beerse, Belgium
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [1] A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.
    Voortman, J
    Smit, EF
    Kuenen, BC
    Pinedo, HM
    van Groeningen, C
    van den Eertwegh, AJ
    Brouwer, D
    van de Velde, H
    Giaccone, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 160S - 160S
  • [2] A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors
    Voortman, Jens
    Smit, Egbert F.
    Honeywell, Richard
    Kuenen, Bart C.
    Peters, Godefridus J.
    de Velde, Helgi van
    Giaccone, Giuseppe
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3642 - 3651
  • [3] Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors
    Frederik Marmé
    Carlos Gomez-Roca
    Kristina Graudenz
    Funan Huang
    John Lettieri
    Carol Peña
    Zuzana Jirakova Trnkova
    Jan Eucker
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 727 - 737
  • [4] Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors
    Marme, Frederik
    Gomez-Roca, Carlos
    Graudenz, Kristina
    Huang, Funan
    Lettieri, John
    Pena, Carol
    Trnkova, Zuzana Jirakova
    Eucker, Jan
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (04) : 727 - 737
  • [5] Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States
    Andrea Wang-Gillam
    William Schelman
    Stacey Ukrainskyj
    Caly Chien
    Martha Gonzalez
    Zhao Yang
    Marek Kania
    Heather Yeckes-Rodin
    [J]. Investigational New Drugs, 2023, 41 (6) : 851 - 860
  • [6] Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States
    Wang-Gillam, Andrea
    Schelman, William
    Ukrainskyj, Stacey
    Chien, Caly
    Gonzalez, Martha
    Yang, Zhao
    Kania, Marek
    Yeckes-Rodin, Heather
    [J]. INVESTIGATIONAL NEW DRUGS, 2023, 41 (06) : 851 - 860
  • [7] A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
    Mettu, Niharika B.
    Ulahannan, Susanna, V
    Bendell, Johanna C.
    Garrido-Laguna, Ignacio
    Strickler, John H.
    Moore, Kathleen N.
    Stagg, Robert
    Kapoun, Ann M.
    Faoro, Leonardo
    Sharma, Sunil
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (05) : 882 - 892
  • [8] A Phase 1b Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0941 in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Lolkema, M.
    Leong, S.
    Voest, E.
    Freas, E.
    Shankar, G.
    Brachmann, R. K.
    Moss, R. A.
    Stein, M. N.
    Mergui-Roelvink, M.
    Schellens, J. H. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 111 - 112
  • [9] Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
    Minami, Hironobu
    Ando, Yuichi
    Ma, Brigette Buig Yue
    Lee, Jih-Hsiang
    Momota, Hiroyuki
    Fujiwara, Yutaka
    Li, Leung
    Fukino, Koichi
    Ito, Koji
    Tajima, Takeshi
    Mori, Asuka
    Lin, Chia-Chi
    [J]. CANCER SCIENCE, 2016, 107 (10) : 1477 - 1483
  • [10] An Open-label Phase 1 Dose-escalation Clinical Trial of a Single Intravenous Administration of Gemcitabine in Dogs with Advanced Solid Tumors
    Marconato, L.
    Finotello, R.
    Bonfanti, U.
    Dacasto, M.
    Beatrice, L.
    Pizzoni, S.
    Leone, V. F.
    Balestra, G.
    Furlanello, T.
    Bley, C. Rohrer
    Aresu, L.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (02): : 620 - 625
12345